Surgical management of hepatocellular carcinoma in Child-Pugh class B cirrhotic patients: Hepatic resection and/or microwave coagulation therapy versus living donor liver transplantation

Annals of Transplantation

Volumn 17, Issue 4, 2012, Pages 11-20

  Harada, Noboru ^a   Shirabe, Ken ^a   Ikeda, Yasuharu ^b   Korenaga, Daisuke ^b   Takenaka, Kenji ^b   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Fukuoka City Hospital   (Japan)

Author keywords

Child Pugh class B; Des gamma carboxy prothrombin; Hepatic resection; Hepatocellular carcinoma; Living donor liver transplantation; Milan criteria

Indexed keywords

DECARBOXYPROTHROMBIN;

ADULT; ARTICLE; CHILD PUGH SCORE; COMPARATIVE STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER TRANSPLANTATION; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MICROWAVE COAGULATION; MICROWAVE THERAPY; OVERALL SURVIVAL; PROPORTIONAL HAZARDS MODEL; RECURRENCE FREE SURVIVAL; RECURRENT DISEASE;

ABLATION TECHNIQUES; CARCINOMA, HEPATOCELLULAR; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MICROWAVES; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84875349330     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/AOT.883689     Document Type: Article

References (33)

1. El-Serag HB, Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 2007; 132: 2557-76
2. Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer, 2001; 94(2): 153-56
3. Bolondi L, Sofia S, Siringo S et al: Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut, 2001; 48: 251-59
4. Sarasin FP, Giostra E, Hadengue A: Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis. Am J Med, 1996; 101: 422-34
5. Bismuth H, Chiche L, Adam R et al: Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg, 1993; 218(2): 145-51
6. Mazzaferro V, Regalia E, Doci R et al: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med, 1996; 334(11): 693-99
7. Llovet JM, Bruix J, Gores GJ: Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy. Hepatology, 2000; 31(4): 1019-21
8. Bruix J, Llovet JM: Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology, 2002; 35(3): 519-24
9. Sarasin FP, Giostra E, Mentha G, Hadengue A: Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective. Hepatology, 1998; 28(2): 436-42
10. Michel J, Suc B, Montpeyroux F, Hachemanne S et al: Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis. J Hepatol, 1997; 26(6): 1274-80
11. Franco D, Capussotti L, Smadja C et al: Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. Gastroenterology, 1990; 98(3): 733-38
12. Fuster J, García-Valdecasas JC, Grande L et al: Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg, 1996; 223(3): 297-302
13. The Liver Cancer Study Group of Japan: Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer, 1994; 15; 74: 2772-80
14. Sugimachi K, Ikeda Y, Tomikawa M et al: Appraisal of hepatic resection in the treatment of hepatocellular carcinoma with severe thrombocytopenia. World J Surg, 2008; 32: 1077-81
15. Hashimoto K, Ikeda Y, Korenaga D et al: Tenyear survival of patients with hepatocellular carcinoma after hepatectomy. Hepatogastroenterology, 2007; 54: 163-66
16. Ryu M, Watanabe K, Yamamoto H: Hepatectomy with microwave tissue coagulation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg, 1998; 5(2): 184-91
17. Sato M, Watanabe Y, Ueda S et al: Microwave coagulation therapy for hepatocellular carcinoma. Gastroenterology, 1996; 110(5): 1507-14
18. Pugh RN, Murray-Lyon IM, Dawson JL et al: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg, 1973; 60(8): 646-49
19. Infante-Rivard C, Esnaola S, Villeneuve JP: Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology, 1987; 7(4): 660-64
20. Ikai I, Yamamoto Y, Yamamoto N et al: Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins. Surg Oncol Clin N Am, 2003; 12(1): 65-75, ix
21. Vauthey JN, Klimstra D, Blumgart LH: A simplified staging system for hepatocellular carcinomas. Gastroenterology, 1995; 108(2): 617-18
22. Kubo S, Nishiguchi S, Hirohashi K et al: Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma. Cancer, 1999 1; 86(5): 793-98
23. Malinchoc M, Kamath PS, Gordon FD et al: A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology, 2000; 31(4): 864-71
24. The Cancer of the Liver Italian Program (CLIP) Investigators: Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology, 2000; 31(4): 840-45
25. Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg, 2004; 240: 205-13
26. Yataco M, Bonatti H, Machicao V et al: Long term survival and complications after liver transplantation in patients with chronic hepatitis B. Ann Transplant, 2010; 15(2): 27-34
27. Soejima Y, Taketomi A, Yoshizumi T et al: Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation, 2007; 83: 893-99
28. Gondolesi GE, Roayaie S, Muñoz L et al: Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg, 2004; 239: 142-49
29. Colombo M, Sangiovanni A: Etiology, natural history and treatment of hepatocellular carcinoma. Antiviral Res, 2003; 60: 145-50
30. Vitale A, Boccagni P, Brolese A et al: Progression of hepatocellular carcinoma before liver transplantation: dropout or liver transplantation? Transplant Proc, 2009; 41: 1264-67
31. Shirabe K, Itoh S, Yoshizumi T et al: The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol, 2007; 95: 235-40
32. Taketomi A, Sanefuji K, Soejima Y et al: Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation, 2009; 87: 531-37
33. Llovet JM, Fuster J, Bruix J; Barcelona-Clínic Liver Cancer Group: The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl, 2004; 10: 115-20